#BEGIN_DRUGCARD DB04100

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
49851

# Chemical_Formula:
C15H8N2O3Re

# Chemical_IUPAC_Name:
15,15,15-tris(hydroxymethyl)-1,12-diaza-15-rhenatetracyclo[10.2.1.0^{5,14}.0^{8,13}]pentadeca-2,4,6,8,10,13-hexaen-15-ylium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)

# HET_ID:
REP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H8N2.3CO.Re/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1;3*1-2;/h1-8H;;;;/q-2;;;;+3

# InChI_Key:
InChIKey=MJGBWBLYZOUDIT-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4100

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
450.443

# Molecular_Weight_Mono:
451.009242919

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1JZI

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.86

# Predicted_LogS:
-2.5

# Predicted_Water_Solubility:
1.55e+00 g/l

# Primary_Accession_No:
DB04100

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17754141

# PubChem_Substance_ID:
46505489

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02771

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[O]#C[Re+]1(C#[O])(C#[O])N2C=CC=C3C=CC4=CC=CN1C4=C23

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:57 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X07317

# Drug_Target_1_GenBank_ID_Protein:
45292

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
azu

# Drug_Target_1_Gene_Sequence:
>447 bp
ATGCTACGTAAACTCGCTGCGGTATCCCTGCTGTCCCTGCTCAGTGCGCCGCTGCTGGCT
GCCGAGTGCTCGGTGGACATCCAGGGTAACGACCAGATGCAGTTCAACACCAATGCCATC
ACCGTCGACAAGAGCTGCAAGCAGTTCACCGTCAACCTGTCCCACCCCGGCAACCTGCCG
AAGAACGTCATGGGCCACAACTGGGTACTGAGCACCGCCGCCGACATGCAGGGCGTGGTC
ACCGACGGCATGGCTTCCGGCCTGGACAAGGATTACCTGAAGCCCGACGACAGCCGCGTC
ATCGCCCACACCAAGCTGATCGGCTCGGGCGAGAAGGACTCGGTGACCTTCGACGTCTCC
AAGCTGAAGGAAGGCGAGCAGTACATGTTCTTCTGCACCTTCCCGGGCCACTCCGCGCTG
ATGAAGGGCACCCTGACCCTGAAGTGA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
1420141	van de Kamp M, Canters GW, Wijmenga SS, Lommen A, Hilbers CW, Nar H, Messerschmidt A, Huber R: Complete sequential 1H and 15N nuclear magnetic resonance assignments and solution secondary structure of the blue copper protein azurin from Pseudomonas aeruginosa. Biochemistry. 1992 Oct 27;31(42):10194-207.
1633865	Nar H, Messerschmidt A, Huber R, van de Kamp M, Canters GW: Crystal structure of Pseudomonas aeruginosa apo-azurin at 1.85 A resolution. FEBS Lett. 1992 Jul 20;306(2-3):119-24.
2116366	Hoitink CW, Woudt LP, Turenhout JC, van de Kamp M, Canters GW: Isolation and sequencing of the Alcaligenes denitrificans azurin-encoding gene: comparison with the genes encoding blue copper proteins from Pseudomonas aeruginosa and Alcaligenes faecalis. Gene. 1990 May 31;90(1):15-20.
2537198	Arvidsson RH, Nordling M, Lundberg LG: The azurin gene from Pseudomonas aeruginosa. Cloning and characterization. Eur J Biochem. 1989 Jan 15;179(1):195-200.
3100334	Canters GW: The azurin gene from Pseudomonas aeruginosa codes for a pre-protein with a signal peptide. Cloning and sequencing of the azurin gene. FEBS Lett. 1987 Feb 9;212(1):168-72.
8568881	Hammann C, Messerschmidt A, Huber R, Nar H, Gilardi G, Canters GW: X-ray crystal structure of the two site-specific mutants Ile7Ser and Phe110Ser of azurin from Pseudomonas aeruginosa. J Mol Biol. 1996 Jan 26;255(3):362-6.
9047369	Hammann C, van Pouderoyen G, Nar H, Gomis Ruth FX, Messerschmidt A, Huber R, den Blaauwen T, Canters GW: Crystal structures of modified apo-His117Gly and apo-His46Gly mutants of Pseudomonas aeruginosa azurin. J Mol Biol. 1997 Feb 21;266(2):357-66.
9100002	Karlsson BG, Tsai LC, Nar H, Sanders-Loehr J, Bonander N, Langer V, Sjolin L: X-ray structure determination and characterization of the Pseudomonas aeruginosa azurin mutant Met121Glu. Biochemistry. 1997 Apr 8;36(14):4089-95.
98639	Adman ET, Stenkamp RE, Sieker LC, Jensen LH: A crystallographic model for azurin a 3 A resolution. J Mol Biol. 1978 Jul 25;123(1):35-47.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2443

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
16009

# Drug_Target_1_Name:
Azurin

# Drug_Target_1_Number_of_Residues:
148

# Drug_Target_1_PDB_ID:
1JZJ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00127	Copper-bind

# Drug_Target_1_Protein_Sequence:
>Azurin precursor
MLRKLAAVSLLSLLSAPLLAAECSVDIQGNDQMQFNTNAITVDKSCKQFTVNLSHPGNLP
KNVMGHNWVLSTAADMQGVVTDGMASGLDKDYLKPDDSRVIAHTKLIGSGEKDSVTFDVS
KLKEGEQYMFFCTFPGHSALMKGTLTLK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-20

# Drug_Target_1_Specific_Function:
Transfers electrons from cytochrome c551 to cytochrome oxidase

# Drug_Target_1_SwissProt_ID:
P00282

# Drug_Target_1_SwissProt_Name:
AZUR_PSEAE

# Drug_Target_1_Synonyms:
Azurin precursor

# Drug_Target_1_Theoretical_pI:
6.93

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04100
